C&R Research Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Public

  • Employees
  • 526

Employees

  • Stock Symbol
  • 359090

Stock Symbol

  • Investments
  • 7

  • Share Price
  • $1.57
  • (As of Friday Closing)

C&R Research General Information

Description

C&R Research Inc provides a quotation on clinical trial service. The company is a contract research organization specializing in clinical trial design, consulting, monitoring, data management, and licensing for clients like pharmaceutical companies and biotech ventures.

Contact Information

Website
www.cnrres.com
Formerly Known As
CNR Consulting
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • C&R Building
  • 412 Yeoksam-Ro, Gangnam-Gu
  • Seoul, Gangnam
  • South Korea
+82
Primary Industry
BPO/Outsource Services
Other Industries
Other Healthcare Services
Drug Discovery
Stock Exchange
KRX
Corporate Office
  • C&R Building
  • 412 Yeoksam-Ro, Gangnam-Gu
  • Seoul, Gangnam
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

C&R Research Stock Performance

As of 13-Nov-2026, C&R Research’s stock price is $1.57. Its current market cap is $18M with 11.5M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.57 $1.46 $1.08 - $4.01 $18M 11.5M 8.98K -$0.25

C&R Research Financials Summary

As of 30-Jun-2026, C&R Research has a trailing 12-month revenue of $43.8M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 15,676 32,282 40,058 48,524
Revenue 43,788 45,661 43,746 42,145
EBITDA 316 1,486 3,502 5,353
Net Income 1,145 1,817 2,813 4,254
Total Assets 60,655 58,810 58,115 60,409
Total Debt 10,242 4,991 3,698 5,039
Public Fundamental Data provided by Morningstar, Inc. disclaimer

C&R Research Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore C&R Research‘s full profile, request access.

Request a free trial

C&R Research Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

C&R Research Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230120168-A1 Method and system for blockchain-based medicine-taking management for clinical trial subject Inactive 29-Oct-2019
WO-2021085703-A1 Method and system for blockchain-based medicine-taking management for clinical trial subject Inactive 29-Oct-2019

C&R Research Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

C&R Research Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore C&R Research‘s full profile, request access.

Request a free trial

C&R Research Investments & Acquisitions (7)

C&R Research’s most recent deal was a Merger/Acquisition with EPS International Korea. The deal was made on 13-Jul-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
EPS International Korea 13-Jul-2026 Merger/Acquisition Drug Discovery
mediplexus 08-Jan-2026 Merger/Acquisition Discovery Tools (Healthcare)
ABC Bioscience 01-Oct-2023 Joint Venture Consulting Services (B2B)
NH Corporate Acquisition Purpose No. 17 17-Dec-2021 Merger/Acquisition Special Purpose Acquisition Company (SPAC)
Trial Informatics 31-May-2021 Seed Round Discovery Tools (Healthcare)
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

C&R Research ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Diversified Financials

Industry

Rank

Percentile

Asset Management and Custody Services

Subindustry

Rank

Percentile

To view C&R Research’s complete esg history, request access »

C&R Research Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
EPS International Korea Seongdong-gu, South Korea 2011

C&R Research FAQs

  • When was C&R Research founded?

    C&R Research was founded in 1997.

  • Where is C&R Research headquartered?

    C&R Research is headquartered in Seoul, South Korea.

  • What is the size of C&R Research?

    C&R Research has 526 total employees.

  • What industry is C&R Research in?

    C&R Research’s primary industry is BPO/Outsource Services.

  • Is C&R Research a private or public company?

    C&R Research is a Public company.

  • What is C&R Research’s stock symbol?

    The ticker symbol for C&R Research is 359090.

  • What is the current stock price of C&R Research?

    As of 13-Nov-2026 the stock price of C&R Research is $1.57.

  • What is the current market cap of C&R Research?

    The current market capitalization of C&R Research is $18M.

  • What is C&R Research’s current revenue?

    The trailing twelve month revenue for C&R Research is $43.8M.

  • What is C&R Research’s annual earnings per share (EPS)?

    C&R Research’s EPS for 12 months was -$0.25.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process